Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Oncologic mistletoe therapy: physicians' use and estimation of efficiency].

K Münstedt1, A Entezami, U Kullmer

  • 1Zentrum für Frauenheilkunde und Geburtshilfe, Philipps-Universität Marburg. muensted@post.med.uni-marburg.de

Deutsche Medizinische Wochenschrift (1946)
|November 15, 2000
PubMed
Summary

Physicians in Germany frequently use mistletoe extracts for cancer therapy despite lacking strong evidence of efficacy. Doctors

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Complementary or alternative medicine in oncology : Chances or risks?]

Innere Medizin (Heidelberg, Germany)·2023
Same author

A Systematic Review of the Benefit of B-Vitamins as a Complementary Treatment in Cancer Patients.

Nutrition and cancer·2022
Same author

Impact of patients' refusal to undergo adjuvant treatment measures on survival.

Breast cancer research and treatment·2020
Same author

A Pilot Study of Side Effects of Cancer Therapies and their Impact on Satisfaction with Life.

Cancer investigation·2019
Same author

How are Interactions Taken into Account in Studies on Conventional and Complementary Therapies for Breast Cancer Patients with Menopausal Complaints?

Geburtshilfe und Frauenheilkunde·2017
Same author

Survival after neoadjuvant chemotherapy with or without bevacizumab or everolimus for HER2-negative primary breast cancer (GBG 44-GeparQuinto)†.

Annals of oncology : official journal of the European Society for Medical Oncology·2014

Area of Science:

  • Oncology
  • Complementary and Alternative Medicine

Background:

  • Mistletoe extracts are a prominent unorthodox therapy in German oncology.
  • Despite decades of use, robust evidence for mistletoe extract efficacy is lacking.
  • Physicians are key providers of unconventional cancer therapies.

Purpose of the Study:

  • To investigate physicians' experiences and attitudes towards mistletoe extracts and other unconventional cancer therapies.
  • To assess physician-perceived efficacy and reasons for using mistletoe extracts.

Main Methods:

  • Cross-sectional study involving 202 physicians in private practice.
  • Structured, pretested questionnaire on unconventional cancer therapies, attitudes, and perceived efficiency.
  • Response rate of 80.2%.

Related Experiment Videos

Main Results:

  • 79.2% of physicians provide unconventional therapies, with older, experienced doctors more likely to do so.
  • 44.4% of these physicians prefer mistletoe extracts.
  • Mistletoe extracts were estimated to have lower remission rates (6-15%) and quality of life improvements compared to other unconventional methods.
  • Physicians used mistletoe extracts less frequently due to conviction in its efficacy (p=0.025).

Conclusions:

  • Clinical studies are essential to validate potential benefits of mistletoe extracts.
  • The popularity of mistletoe extracts persists despite physicians' moderate judgments on its efficiency.